Nervonik is a medical device company developing cutting-edge peripheral nerve stimulation (PNS) solutions to treat chronic pain. Leveraging advanced, proprietary, wireless power, and closed-loop sensing technologies, Nervonik is committed to providing minimally invasive, effective, and patient-centric treatment options. Nervonik is focused on advancing clinical research and achieving regulatory milestones to bring its innovative therapies to market.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
03/04/25	$13,000,000	Series A	Correlation Ventures Foothill Ventures US Venture Partners	undisclosed
04/27/26	$52,500,000	Series B	Amzak Health Elevage Medical Technologies Foothill Ventures Lumira Ventures ShangBay Capital US Venture Partners	undisclosed